Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Measuring participation in an evidence-based practice: illness management and recovery group attendance.

McGuire AB, Bonfils KA, Kukla M, Myers L, Salyers MP.

Psychiatry Res. 2013 Dec 30;210(3):684-9. doi: 10.1016/j.psychres.2013.08.008. Epub 2013 Sep 5.

2.

A pilot study of an illness management and recovery program in discharged patients with schizophrenia.

Lin EC, Shao WC, Chan CH, Shiau S, Wang HS, Huang SC.

J Nurs Res. 2013 Dec;21(4):270-7. doi: 10.1097/jnr.0000000000000004.

PMID:
24241276
4.

A randomized controlled trial of an adapted Illness Management and Recovery program for people with schizophrenia awaiting discharge from a psychiatric hospital.

Lin EC, Chan CH, Shao WC, Lin MF, Shiau S, Mueser KT, Huang SC, Wang HS.

Psychiatr Rehabil J. 2013 Dec;36(4):243-9. doi: 10.1037/prj0000013.

PMID:
24320832
5.

Levels of patient activation among adults with schizophrenia: associations with hope, symptoms, medication adherence, and recovery attitudes.

Kukla M, Salyers MP, Lysaker PH.

J Nerv Ment Dis. 2013 Apr;201(4):339-44. doi: 10.1097/NMD.0b013e318288e253.

PMID:
23538980
6.

Factors related to non-attendance in a population based melanoma screening program.

Bergenmar M, Törnberg S, Brandberg Y.

Psychooncology. 1997 Sep;6(3):218-26.

PMID:
9313288
7.

A randomized controlled trial of illness management and recovery with an active control group.

Salyers MP, McGuire AB, Kukla M, Fukui S, Lysaker PH, Mueser KT.

Psychiatr Serv. 2014 Aug 1;65(8):1005-11. doi: 10.1176/appi.ps.201300354.

PMID:
24733680
8.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.

Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders.

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):1-30. Review.

PMID:
15660702
10.

Factors associated with good self-management in older adults with a schizophrenic disorder compared with older adults with physical illnesses.

Stein-Parbury J, Gallagher R, Chenoweth L, Luscombe GM.

J Psychiatr Ment Health Nurs. 2012 Mar;19(2):146-53. doi: 10.1111/j.1365-2850.2011.01767.x. Epub 2011 Aug 17.

PMID:
22070648
11.

Factors influencing participation in a vascular disease prevention lifestyle program among participants in a cluster randomized trial.

Laws RA, Fanaian M, Jayasinghe UW, McKenzie S, Passey M, Davies GP, Lyle D, Harris MF.

BMC Health Serv Res. 2013 May 31;13:201. doi: 10.1186/1472-6963-13-201.

12.

A randomized controlled trial of the effectiveness of the illness management and recovery program.

Hasson-Ohayon I, Roe D, Kravetz S.

Psychiatr Serv. 2007 Nov;58(11):1461-6.

PMID:
17978257
13.

The role of subjective illness beliefs and attitude toward recovery within the relationship of insight and depressive symptoms among people with schizophrenia spectrum disorders.

Cavelti M, Beck EM, Kvrgic S, Kossowsky J, Vauth R.

J Clin Psychol. 2012 Apr;68(4):462-76. doi: 10.1002/jclp.20872. Epub 2012 Feb 13.

PMID:
22331634
14.

Effectiveness of a peer-led self-management programme for people with schizophrenia: protocol for a randomized controlled trial.

Chan SW, Li Z, Klainin-Yobas P, Ting S, Chan MF, Eu PW.

J Adv Nurs. 2014 Jun;70(6):1425-35. doi: 10.1111/jan.12306. Epub 2013 Nov 14.

PMID:
24224787
15.

Repeat attenders at National Health Service walk-in centres - a descriptive study using routine data.

Maheswaran R, Pearson T, Jiwa M.

Public Health. 2009 Jul;123(7):506-10. doi: 10.1016/j.puhe.2009.06.008. Epub 2009 Jul 14.

PMID:
19604528
16.

Development and usability testing of FOCUS: a smartphone system for self-management of schizophrenia.

Ben-Zeev D, Kaiser SM, Brenner CJ, Begale M, Duffecy J, Mohr DC.

Psychiatr Rehabil J. 2013 Dec;36(4):289-96. doi: 10.1037/prj0000019. Epub 2013 Sep 9.

17.

Patient activation in schizophrenia: insights from stories of illness and recovery.

Salyers MP, Matthias MS, Sidenbender S, Green A.

Adm Policy Ment Health. 2013 Sep;40(5):419-27. doi: 10.1007/s10488-012-0435-7.

PMID:
22936284
18.

Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE).

Crawford MJ, Killaspy H, Barnes TR, Barrett B, Byford S, Clayton K, Dinsmore J, Floyd S, Hoadley A, Johnson T, Kalaitzaki E, King M, Leurent B, Maratos A, O'Neill FA, Osborn D, Patterson S, Soteriou T, Tyrer P, Waller D; MATISSE project team.

Health Technol Assess. 2012;16(8):iii-iv, 1-76. doi: 10.3310/hta16080.

19.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

20.

Attendance patterns of older adults in a health promotion program.

Watkins AJ, Kligman EW.

Public Health Rep. 1993 Jan-Feb;108(1):86-90.

Items per page

Supplemental Content

Write to the Help Desk